pharmaceutical-investing Opiant Pharmaceuticals Announces Contract with Biomedical Advanced Research and Development Authority for Up to $4.6 Million to Accelerate Development of OPNT003
pharmaceutical-investing Summit Awarded Additional $12 Million by BARDA for Phase 3 Development Programme of Ridinilazole for the Treatment of C. difficile Infection
K92 Mining Announces 2026 Operational Guidance - Significant Production Growth and Exploration Program Planned
Franco-Nevada Declares 19th Consecutive Annual Dividend Increase and Announces Chair Succession Plans
EMP METALS ADVANCES CONSTRUCTION OF PROJECT AURORA DEMONSTRATION PLANT BY COMPLETING INTERIOR FINISHING